bar_chartAcorda Therapeutics, Inc.
ACOR | Healthcare | Biotechnologybar_chartPerformance
bar_chartCash Flow
bar_chartInstitutional Holders
| Holder | % Out | Shares |
|---|---|---|
| Blackrock Inc. | 15.26% | 7,321,920 |
| FMR, LLC | 10.82% | 5,191,573 |
| Vanguard Group, Inc. (The) | 9.23% | 4,430,998 |
| Renaissance Technologies, LLC | 7.97% | 3,822,645 |
| Dimensional Fund Advisors LP | 5.8% | 2,785,162 |
| Acadian Asset Management | 3.95% | 1,893,678 |
| Point72 Asset Management, L.P. | 3.31% | 1,589,600 |
| Partner Fund Management, L.P. | 3.18% | 1,526,174 |
| State Street Corporation | 3.11% | 1,492,994 |
| Invesco Ltd. | 2.05% | 984,266 |
bar_chartMutual Fund Holders
| Holder | % Out | Shares |
|---|---|---|
| Fidelity Select Portfolios - Biotechnology | 7.9% | 3,788,526 |
| iShares Core S&P Smallcap ETF | 6.57% | 3,151,192 |
| Fidelity Advisor Biotechnology Fund | 5.39% | 2,586,547 |
| Vanguard Total Stock Market Index Fund | 2.85% | 1,366,942 |
| iShares Russell 2000 ETF | 1.94% | 931,166 |
| iShares S&P Smallcap 600 Value ETF | 1.77% | 848,838 |
| Vanguard Tax Managed Fund-Small Cap Fund | 1.65% | 792,850 |
| DFA U.S. Small Cap Series | 1.65% | 791,159 |
| Vanguard Explorer Fund, Inc. | 1.62% | 775,332 |
| DFA U.S. Targeted Value Portfolio | 1.55% | 743,079 |